JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rech, R. H.
Right arrow Articles by Moore, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rech, R. H.
Right arrow Articles by Moore, K. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 160, Issue 2, 326-335, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


BEHAVIORAL EFFECTS OF agr-METHYLTYROSINE AFTER PRIOR DEPLETION OF BRAIN CATECHOLAMINES

R. H. Rech 1, L. A. Carr 1, and K. E. Moore 1

1 Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire, and Department of Pharmacology, Michigan State University, East Lansing, Michigan

Small doses of agr-methyltyrosine (agr-MT; 50 mg/kg) and reserpine (0.5 mg/kg), which by themselves had little influence on conditioned avoidance behavior and locomotor activity of rats, greatly disrupted these responses when administered together. This combination also reduced brain stores of norepinephrine (NE) and dopamine (D) more than either drug alone. Three days after a larger dose of reserpine (2 mg/kg), rats recovered from the behavioral depression but the brain levels of NE and D were still very low. At this time agr-MT (50 mg/kg) markedly impaired avoidance responding, rotarod performance and motor activity, and also further reduced NE and D. The depressant effects of subsequent agr-MT injections diminished as the brain stores of NE and D returned toward control values (7-14 days after reserpine). agr-MT also depressed behavioral responses in animals pretreated with tetrabenazine and Ro 4-1284; the time course of these behavioral effects again paralleled that of the reduced brain content of NE and D. agr-MT did not impair behavior when administered to rats just recovering from central depression induced by drugs which do not alter brain catecholamine levels (fluphenazine, pentobarbital or urethane). These results support the proposal that agr-MT-induced behavioral effects relate to a lack of NE and/or D in the brain.

Submitted on May 29, 1967
Accepted on January 8, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.